Kiyoshi Ando

16.0k citations
343 papers · 10.1k · 3 hit papers · h-index 48

Impact in

  • Genetics top 0.2%
    • Mesenchymal stem cell research
    • Chronic Lymphocytic Leukemia Research
    • Lymphoma Diagnosis and Treatment
    • Spine and Intervertebral Disc Pathology

Papers in

    • Hematopoietic Stem Cell Transplantation 38
    • Acute Myeloid Leukemia Research 23
    • Multiple Myeloma Research and Treatments 23
    • Lymphoma Diagnosis and Treatment 80

Kiyoshi Ando

332 papers receiving 9.9k citations

Kiyoshi Ando's Hit Papers

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma 2017 · 479 citations
4790+4+9Years since publication100200300400

Peers

Kiyoshi Ando
Comparison fields: 5 of 142
  • Genetics 2.0k
  • Pathology and Forensic Medicine 2.9k
  • Hematology 1.7k
  • Immunology 1.9k
  • Oncology 1.9k
Replace Tadashi Yoshino with:
Tadashi Yoshino Japan
Xu Cao United States
K C Gatter United Kingdom
Beatrice Nico Italy
Elaine Lyon United States
Costantino Pitzalis United Kingdom
Kathleen C. Flanders United States
Tatsutoshi Nakahata Japan
Vito Pistoia Italy
Armin Kurtz Germany
Kiyoshi Ando relative to Tadashi Yoshino Japan Tadashi Yoshino's profile →
Citations per field
00.5×3.7×
Tadashi Yoshino · 1×
Citations per year

Countries citing papers authored by Kiyoshi Ando

Since Specialization
Citations

This map shows the geographic impact of Kiyoshi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Ando more than expected).

Fields of papers citing papers by Kiyoshi Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoshi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Ando. The network helps show where Kiyoshi Ando may publish in the future.

Co-authors

The 25 scholars most cited alongside Kiyoshi Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kiyoshi Ando Line = papers co-authored together Kiyoshi Ando links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 343 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
Hit paper breakdown →
2017479
2 2004453
3
Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc
Hit paper breakdown →
2012375
4 2003346
5 2005309
6 2008300
7 2005296
8
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Hit paper breakdown →
2014293
9 2002280
10 2011241
11 2005226
12 2006175
13 2002153
14 2008148
15 2003145
16 1999135
17 2013117
18 1999109
19 2001108
20 201190

About Kiyoshi Ando

Kiyoshi Ando is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Genetics and Molecular Biology, having authored 343 papers that have together received 10.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (80 papers), Chronic Lymphocytic Leukemia Research (49 papers), Hematopoietic Stem Cell Transplantation (38 papers), Immune Cell Function and Interaction (32 papers), Viral-associated cancers and disorders (27 papers), Acute Myeloid Leukemia Research (23 papers), Multiple Myeloma Research and Treatments (23 papers) and CAR-T cell therapy research (23 papers). The work is most often cited by research in Genetics (2.0k citations), Pathology and Forensic Medicine (2.9k citations), Hematology (1.7k citations), Immunology (1.9k citations) and Oncology (1.9k citations). Kiyoshi Ando has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Tomomitsu Hotta, Shunichi Kato, Daisuke Sakai, Joji Mochida, Takashi Yahata, Yoshihiko Nakamura, Tomoko Nakai, Hiroshi Kawada, Yukari Muguruma and Toru Iwashina. Their work appears in journals such as Blood, International Journal of Hematology, Cancer Science, Journal of Clinical Oncology and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact